These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7398079)

  • 1. Stabilization of human breast cancer progesterone (5020) receptor by sodium molybdate.
    Anderson KM; Marogil M; Bonomi PD; Hendrickson C; Economou S
    Clin Chim Acta; 1980 May; 103(3):367-73. PubMed ID: 7398079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium molybdate increases the amount of progesterone and estrogen receptor detected in certain human breast cancer cytosols.
    Anderson KM; Phelan J; Marogil M; Hendrickson C; Economou S
    Steroids; 1980 Mar; 35(3):273-80. PubMed ID: 7189611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversibility of the stabilization effect of sodium molybdate on uterine estrogen and progesterone receptors of the vervet monkey.
    Klein T; Potgieter HC; Spies JH; van der Watt JJ; Savage N
    J Recept Res; 1985; 5(4):267-95. PubMed ID: 4057178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine progesterone receptor: stabilization and physicochemical alterations produced by sodium molybdate.
    Chen TJ; MacDonald RG; Leavitt WW
    Biochemistry; 1981 Jun; 20(12):3405-11. PubMed ID: 7260046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the effect of sodium molybdate and diisopropylfluorophosphate on the human myometrial estrogen and progesterone receptors.
    Lukola A; Punnonen R
    J Steroid Biochem; 1983 Mar; 18(3):231-5. PubMed ID: 6827828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of molybdate on classification of estrogen and progesterone receptor status in human breast cancer.
    Borjesson BW; Tesoriero CJ
    J Steroid Biochem; 1985 Dec; 23(6A):949-53. PubMed ID: 4094423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of temperature, storage and sodium molybdate on the analysis of estrogen and progesterone receptors in rabbit uterine tissue and gynecologic tumor.
    Leung BS
    Horm Res; 1984; 19(4):243-52. PubMed ID: 6745845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation of a rabbit progesterone receptor from an 8S form to 5.5S and 4S forms.
    Seeley DH; Costas PD
    Mol Cell Endocrinol; 1983 May; 30(2):161-78. PubMed ID: 6303876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic analysis of human breast cancer progesterone receptors. 2. Structure, phosphorylation, and processing.
    Wei LL; Sheridan PL; Krett NL; Francis MD; Toft DO; Edwards DP; Horwitz KB
    Biochemistry; 1987 Sep; 26(19):6262-72. PubMed ID: 3689774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial characterization of protease(s) in human breast cancer cytosols that can degrade estrogen and progesterone receptors selectively.
    Maeda K; Tsuzimura T; Nomura Y; Sato B; Matsumoto K
    Cancer Res; 1984 Mar; 44(3):996-1001. PubMed ID: 6362861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat uterine progesterone receptor: stabilization of hormone-binding components for biochemical analyses.
    Walters MR
    Arch Biochem Biophys; 1983 Sep; 225(2):656-66. PubMed ID: 6625605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and progesterone receptors in the uterus of the vervet monkey.
    Potgieter HC; Spies JH; Klein T; Thierry M; van der Watt JJ
    J Recept Res; 1985; 5(2-3):193-218. PubMed ID: 4040971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of a non-hormone-binding 90-kilodalton protein in the nontransformed 8S form of the rabbit uterus progesterone receptor.
    Renoir JM; Buchou T; Baulieu EE
    Biochemistry; 1986 Oct; 25(21):6405-13. PubMed ID: 3790528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of calf uterine progesterone receptor: analysis of the process when receptor is bound to progesterone and RU38486.
    Moudgil VK; Hurd C
    Biochemistry; 1987 Aug; 26(16):4993-5001. PubMed ID: 3663641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of the 8S complex in oestrogen receptor recognition.
    Marsigliante S; Puddefoot JR; Barker S; Goode AW; Vinson GP
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):703-11. PubMed ID: 1958507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiprogesterone RU486 stabilizes the heterooligomeric, non-DNA-binding, 8S-form of the rabbit uterus cytosol progesterone receptor.
    Renoir JM; Radanyi C; Baulieu EE
    Steroids; 1989; 53(1-2):1-20. PubMed ID: 2772964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of R5020 and RU486 binding to progesterone receptor from calf uterus.
    Hurd C; Moudgil VK
    Biochemistry; 1988 May; 27(10):3618-23. PubMed ID: 3408715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancies between antibody (EIA) and saturation analysis of oestrogen receptor content in breast tumour samples.
    Marsigliante S; Puddefoot JR; Barker S; Gledhill J; Vinson GP
    J Steroid Biochem Mol Biol; 1990 Dec; 37(5):643-8. PubMed ID: 2278849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitfalls in the Dextran-coated charcoal assay of estrogen receptors in breast cancer tissue.
    Pettersson KS; Vanharanta RM; Söderholm JR
    J Steroid Biochem; 1985 Jan; 22(1):39-45. PubMed ID: 2579292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of heparin with the cytosol progesterone receptor from human mammary tumours: separate estimation of the 4 and 7 S binding components with a simple dextran-charcoal assay.
    Thorsen T
    J Steroid Biochem; 1981 Feb; 14(2):221-7. PubMed ID: 7193783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.